uniQure
Feilong Sun is a seasoned formulation scientist specializing in drug product development, currently working at uniQure since September 2020, where roles include Formulation Scientist and previously Jr. Scientist. Prior experience includes serving as a Postdoctoral Researcher at Delft University of Technology from November 2018 to September 2020, and as a Formulation Chemist at Ceradis from March 2018 to November 2018. Feilong Sun earned a PhD in Pharmaceutics at Utrecht University between 2013 and 2018, after completing a Master's joint program in Pharmaceutical Sciences at the Institute of Process Engineering, Chinese Academy of Sciences in collaboration with Shenyang Pharmaceutical University (2012-2013), and a Master's degree in Pharmaceutical Sciences from Shenyang Pharmaceutical University (2010-2013). The academic journey began with a Bachelor's degree in Pharmacy from Zhengzhou University (2006-2010).
This person is not in any teams
This person is not in any offices
uniQure
2 followers
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.